Trial Profile
Multi-center Phase II Trial of Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy (SMA CARNI-VAL Trial).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Valproic acid (Primary) ; Carnitine
- Indications Spinal muscular atrophy
- Focus Adverse reactions; Therapeutic Use
- Acronyms SMA CARNI-VAL Trial
- 06 Apr 2009 New trial record